Skip to main content

We are pleased to share that we have been ranked among top 10 law firms in India in the prestigious RSG India Rankings 2019, the most popular barometer of leading Indian law firms published by RSG Consulting.

The firm was also recognized among the leading firms in the country for “Developing Legal Minds” and for “Defending Corporate India” and also shortlisted for “Law Firm of the Decade” at the RSG Grow India Summit 2019.

The summit witnessed a series of insightful discussions. Pravin Anand and Rajiv Maheshwari were invited to speak at the session on “Augmented Lawyers” that was moderated by Yasmin Lambert.

Pravin Anand spoke about his early experiences of using technology, his tryst with developing algorithms in an age when AI was not even on the scene and our contributions to enhancing the usage of technology in Delhi High Court. Rajiv shared his experiences of technology implementation and adoption and of developing Artificial Intelligence, Machine Learning and NLP (Natural Language Processing) based tools.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on India Business Law Journal’ By: Shantanu Sahay and Pratyush Acharya As India moved towards full implementation of the Digital Personal

Treatment of legacy personal data under the DPDPA
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India